Literature DB >> 21522704

5-(4-Pyrid-yl)-1,3,4-thia-diazole-2(3H)-thione.

Xu-Feng Liu, Xing-Hai Liu.   

Abstract

The title compound C(7)H(5)N(3)S(2), occurs as the thione tautomer in the solid state; the dihedral angle between the pyridine and thia-diazole ring planes is 2.08 (6)°. In the crystal, mol-ecules are linked by N-H⋯N hydrogen bonds, generating C(8) chains propagating in [010].

Entities:  

Year:  2010        PMID: 21522704      PMCID: PMC3050180          DOI: 10.1107/S1600536810052116

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For details of the synthesis, see: Song et al. (2005 ▶). For the biological activity of related compounds, see: Liu et al. (2007 ▶, 2009a ▶,b ▶,c ▶).

Experimental

Crystal data

C7H5N3S2 M = 195.26 Monoclinic, a = 7.837 (3) Å b = 15.971 (5) Å c = 6.694 (2) Å β = 103.680 (4)° V = 814.1 (5) Å3 Z = 4 Mo Kα radiation μ = 0.59 mm−1 T = 113 K 0.20 × 0.20 × 0.08 mm

Data collection

Rigaku Saturn CCD diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005 ▶) T min = 0.891, T max = 0.954 8141 measured reflections 1928 independent reflections 1642 reflections with I > 2σ(I) R int = 0.033

Refinement

R[F 2 > 2σ(F 2)] = 0.028 wR(F 2) = 0.076 S = 1.06 1928 reflections 113 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.44 e Å−3 Δρmin = −0.21 e Å−3 Data collection: CrystalClear (Rigaku/MSC, 2005 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810052116/hb5770sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810052116/hb5770Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C7H5N3S2F(000) = 400
Mr = 195.26Dx = 1.593 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 2887 reflections
a = 7.837 (3) Åθ = 2.6–27.9°
b = 15.971 (5) ŵ = 0.59 mm1
c = 6.694 (2) ÅT = 113 K
β = 103.680 (4)°Prism, colorless
V = 814.1 (5) Å30.20 × 0.20 × 0.08 mm
Z = 4
Rigaku Saturn CCD diffractometer1928 independent reflections
Radiation source: fine-focus sealed tube1642 reflections with I > 2σ(I)
graphiteRint = 0.033
Detector resolution: 14.63 pixels mm-1θmax = 27.8°, θmin = 2.6°
ω and φ scansh = −10→10
Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005)k = −20→21
Tmin = 0.891, Tmax = 0.954l = −8→8
8141 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.028Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.076H atoms treated by a mixture of independent and constrained refinement
S = 1.06w = 1/[σ2(Fo2) + (0.0461P)2] where P = (Fo2 + 2Fc2)/3
1928 reflections(Δ/σ)max < 0.001
113 parametersΔρmax = 0.44 e Å3
1 restraintΔρmin = −0.21 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.40446 (4)0.02171 (2)0.20702 (6)0.01704 (11)
S20.60139 (5)−0.14291 (2)0.26909 (6)0.02389 (13)
N10.27180 (16)−0.11033 (7)0.30185 (19)0.0159 (3)
N20.13949 (15)−0.05360 (7)0.28751 (18)0.0151 (2)
N3−0.14570 (15)0.23252 (7)0.15350 (18)0.0154 (3)
C10.42543 (17)−0.08492 (8)0.2646 (2)0.0159 (3)
C20.19024 (17)0.01952 (8)0.2396 (2)0.0138 (3)
C30.07477 (17)0.09310 (8)0.2109 (2)0.0138 (3)
C40.13479 (18)0.17060 (8)0.1615 (2)0.0160 (3)
H40.25150.17720.14630.019*
C50.02020 (18)0.23800 (8)0.1349 (2)0.0159 (3)
H50.06170.29090.10180.019*
C6−0.20252 (18)0.15758 (8)0.2012 (2)0.0156 (3)
H6−0.32020.15290.21450.019*
C7−0.09795 (17)0.08668 (9)0.2320 (2)0.0156 (3)
H7−0.14260.03480.26670.019*
H10.244 (3)−0.1638 (6)0.325 (3)0.047 (6)*
U11U22U33U12U13U23
S10.01417 (18)0.01237 (18)0.0254 (2)−0.00003 (12)0.00638 (15)0.00162 (13)
S20.0190 (2)0.0213 (2)0.0318 (3)0.00798 (14)0.00682 (17)0.00402 (15)
N10.0171 (6)0.0109 (5)0.0204 (7)0.0014 (4)0.0058 (5)0.0016 (5)
N20.0171 (6)0.0117 (5)0.0170 (6)0.0013 (5)0.0048 (5)0.0001 (4)
N30.0164 (6)0.0132 (6)0.0158 (6)−0.0001 (5)0.0021 (5)−0.0016 (4)
C10.0169 (7)0.0139 (6)0.0162 (7)0.0003 (5)0.0025 (5)−0.0005 (5)
C20.0142 (6)0.0137 (6)0.0137 (7)−0.0005 (5)0.0039 (5)−0.0014 (5)
C30.0160 (7)0.0136 (6)0.0115 (7)0.0002 (5)0.0026 (5)−0.0014 (5)
C40.0146 (7)0.0158 (7)0.0179 (7)−0.0014 (5)0.0046 (6)−0.0002 (5)
C50.0183 (7)0.0123 (6)0.0167 (7)−0.0022 (5)0.0037 (6)0.0000 (5)
C60.0142 (6)0.0170 (7)0.0158 (7)−0.0015 (5)0.0040 (6)−0.0017 (5)
C70.0177 (7)0.0126 (7)0.0164 (7)−0.0025 (5)0.0042 (6)−0.0006 (5)
S1—C21.7437 (15)C2—C31.4679 (18)
S1—C11.7452 (15)C3—C41.3916 (19)
S2—C11.6555 (14)C3—C71.3974 (18)
N1—C11.3485 (18)C4—C51.3862 (19)
N1—N21.3631 (16)C4—H40.9500
N1—H10.902 (9)C5—H50.9500
N2—C21.2980 (17)C6—C71.3844 (19)
N3—C51.3378 (18)C6—H60.9500
N3—C61.3417 (17)C7—H70.9500
C2—S1—C189.77 (6)C7—C3—C2120.65 (12)
C1—N1—N2118.98 (11)C5—C4—C3118.43 (13)
C1—N1—H1125.1 (12)C5—C4—H4120.8
N2—N1—H1115.7 (13)C3—C4—H4120.8
C2—N2—N1110.06 (11)N3—C5—C4123.48 (12)
C5—N3—C6117.71 (11)N3—C5—H5118.3
N1—C1—S2127.20 (11)C4—C5—H5118.3
N1—C1—S1107.03 (10)N3—C6—C7123.17 (13)
S2—C1—S1125.77 (8)N3—C6—H6118.4
N2—C2—C3122.50 (12)C7—C6—H6118.4
N2—C2—S1114.16 (10)C6—C7—C3118.57 (12)
C3—C2—S1123.33 (10)C6—C7—H7120.7
C4—C3—C7118.64 (12)C3—C7—H7120.7
C4—C3—C2120.71 (12)
C1—N1—N2—C2−0.77 (17)N2—C2—C3—C7−0.8 (2)
N2—N1—C1—S2−178.87 (10)S1—C2—C3—C7177.65 (11)
N2—N1—C1—S10.50 (15)C7—C3—C4—C5−0.1 (2)
C2—S1—C1—N1−0.08 (10)C2—C3—C4—C5179.66 (12)
C2—S1—C1—S2179.29 (11)C6—N3—C5—C40.3 (2)
N1—N2—C2—C3179.24 (12)C3—C4—C5—N3−0.3 (2)
N1—N2—C2—S10.65 (15)C5—N3—C6—C70.1 (2)
C1—S1—C2—N2−0.34 (11)N3—C6—C7—C3−0.5 (2)
C1—S1—C2—C3−178.92 (12)C4—C3—C7—C60.5 (2)
N2—C2—C3—C4179.40 (13)C2—C3—C7—C6−179.28 (12)
S1—C2—C3—C4−2.14 (19)
D—H···AD—HH···AD···AD—H···A
N1—H1···N3i0.90 (1)1.85 (1)2.7395 (19)169 (2)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1⋯N3i0.90 (1)1.85 (1)2.7395 (19)169 (2)

Symmetry code: (i) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis, antifungal activities and 3D-QSAR study of N-(5-substituted-1,3,4-thiadiazol-2-yl)cyclopropanecarboxamides.

Authors:  Xing-Hai Liu; Yan-Xia Shi; Yi Ma; Chuan-Yu Zhang; Wei-Li Dong; Li Pan; Bao-Lei Wang; Bao-Ju Li; Zheng-Ming Li
Journal:  Eur J Med Chem       Date:  2009-01-22       Impact factor: 6.514

3.  Synthesis, bioactivity and SAR study of N'-(5-substituted-1,3,4-thiadiazol-2-yl)-N-cyclopropylformyl-thioureas as ketol-acid reductoisomerase inhibitors.

Authors:  Xing-Hai Liu; Chuan-Yu Zhang; Wan-Cheng Guo; Yong-Hong Li; Pei-Quan Chen; Teng Wang; Wei-Li Dong; Bao-Lei Wang; Hong-Wei Sun; Zheng-Ming Li
Journal:  J Enzyme Inhib Med Chem       Date:  2009-04       Impact factor: 5.051

4.  Synthesis of some N, n'-diacylhydrazine derivatives with radical-scavenging and antifungal activity.

Authors:  Xing-Hai Liu; Yan-Xia Shi; Yi Ma; Guo-Rong He; Wei-Li Dong; Chuan-Yu Zhang; Bao-Lei Wang; Su-Hua Wang; Bao-Ju Li; Zheng-Ming Li
Journal:  Chem Biol Drug Des       Date:  2009-03       Impact factor: 2.817

5.  Synthesis, bioactivity, theoretical and molecular docking study of 1-cyano-N-substituted-cyclopropanecarboxamide as ketol-acid reductoisomerase inhibitor.

Authors:  Xing-Hai Liu; Pei-Quan Chen; Bao-Lei Wang; Yong-Hong Li; Su-Hua Wang; Zheng-Ming Li
Journal:  Bioorg Med Chem Lett       Date:  2007-04-06       Impact factor: 2.823

  5 in total
  9 in total

1.  (E)-(2,4-Dichloro-benzyl-idene)amino cyclo-propane-carboxyl-ate.

Authors:  Mei-Yi Wang; Ya Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-02

2.  2,5-Bis[(3-chloro-benz-yl)sulfan-yl]-1,3,4-thia-diazole.

Authors:  Na-Bo Sun; Jian-Zhong Jin; Wei Ke
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-05

3.  2-Hydrazinyl-4-methyl-1,3-benzothia-zole.

Authors:  Xu-Feng Liu; Xiao-Yong Yu; Shao-Liang Jiang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-11

4.  2,3-Dichloro-pyridine.

Authors:  Li-Juan Luo; Jian-Quan Weng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-02

5.  1,4-Bis(4-tert-but-ylbenz-yl)piperazine.

Authors:  Li-Juan Luo; Jian-Quan Weng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-29

6.  4-[(2-Bromo-benzyl-idene)amino]-3-(pyridin-4-yl)-1H-1,2,4-triazole-5(4H)-thione.

Authors:  Wei Gao; Xian Li; Xin-Ling Wang; Jing Yang; Xue-Fen Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-02

7.  2,2'-(Piperazine-1,4-di-yl)diacetonitrile.

Authors:  Wei Gao; Jing Yang; Xin-Ling Wang; Ning Zhou; Xue-Fen Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-19

8.  3-Meth-oxy-4-methyl-1H-1,2,4-triazol-5(4H)-one monohydrate.

Authors:  Wei Gao; Xin-Ling Wang; Jing Yang; Xue-Fen Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-31

9.  Synthesis, structure and insecticidal activities of some novel amides containing N-pyridylpyrazole moeities.

Authors:  Wei-Li Dong; Jing-Ying Xu; Li-Xia Xiong; Zheng-Ming Li
Journal:  Molecules       Date:  2012-08-31       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.